Dianthus Therapeutics | MGTA - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Akebia Therapeutics USD 162.64M 22.2M 2026-03
Alaunos Therapeutics USD 354K 1.03M 2026-03
Avita Medical AUD 10.24M 1.98M 2025-12
Celltrion KRW 56.79B 6.92B 2026-03
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
IQVIA Holdings USD 1.95B 33M 2026-03
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 1.91B 687M 2026-03
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Organon & Co USD 1.12B 542M 2026-03
Pharma Mar EUR 48.86M 31.05M 2026-03
Qiagen NV USD 839M 516.58M 2025-12
Revvity USD 860.32M 59.54M 2026-03
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 1.8B 481.8M 2026-03
Xeris Pharmaceuticals USD 111.75M 708K 2026-03
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03